Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
230 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Saint Joseph'S Hospital and Medical Center
Phoenix, Arizona, United States
- Mayo Clinic in Arizona
Scottsdale, Arizona, United States
- University of Arizona Cancer Center-North Campus
Tucson, Arizona, United States
- Providence Saint Joseph Medical Center/disney Family Cancer Center
Burbank, California, United States
- John Muir Medical Center-Concord
Concord, California, United States
- Uc San Diego Moores Cancer Center
La Jolla, California, United States
- Ucla / Jonsson Comprehensive Cancer Center
Los Angeles, California, United States
- Palo Alto Medical Foundation-Gynecologic Oncology
Mountain View, California, United States
- San Diego Va Medical Center
San Diego, California, United States
- Uc San Diego Medical Center - Hillcrest
San Diego, California, United States
- Ucsf Medical Center-Mount Zion
San Francisco, California, United States
- John Muir Medical Center-Walnut Creek
Walnut Creek, California, United States
- Uchealth University of Colorado Hospital
Aurora, Colorado, United States
- Rocky Mountain Gynecologic Oncology Pc
Englewood, Colorado, United States
- Hartford Hospital
Hartford, Connecticut, United States
- Smilow Cancer Hospital Care Center at Saint Francis
Hartford, Connecticut, United States
- the Hospital of Central Connecticut
New Britain, Connecticut, United States
- Yale University
New Haven, Connecticut, United States
- Beebe Medical Center
Lewes, Delaware, United States
- Christiana Care Health System-Christiana Hospital
Newark, Delaware, United States
- Medstar Washington Hospital Center
Washington D.C., District of Columbia, United States
- Morton Plant Hospital
Clearwater, Florida, United States
- Mayo Clinic in Florida
Jacksonville, Florida, United States
- University of Miami Miller School of Medicine-Sylvester Cancer Center
Miami, Florida, United States
- Adventhealth Orlando
Orlando, Florida, United States
- Orlando Health Cancer Institute
Orlando, Florida, United States
- Central Georgia Gynecologic Oncology
Macon, Georgia, United States
- Memorial Health University Medical Center
Savannah, Georgia, United States
- Hawaii Cancer Care Inc - Waterfront Plaza
Honolulu, Hawaii, United States
- Kapiolani Medical Center for Women and Children
Honolulu, Hawaii, United States
- Queen'S Cancer Center - Kuakini
Honolulu, Hawaii, United States
- Queen'S Medical Center
Honolulu, Hawaii, United States
- Straub Clinic and Hospital
Honolulu, Hawaii, United States
- the Cancer Center of Hawaii-Liliha
Honolulu, Hawaii, United States
- University of Hawaii Cancer Center
Honolulu, Hawaii, United States
- Wilcox Memorial Hospital and Kauai Medical Clinic
Lihue, Hawaii, United States
- Maui Memorial Medical Center
Wailuku, Hawaii, United States
- Pacific Cancer Institute of Maui
Wailuku, Hawaii, United States
- Pali Momi Medical Center
‘Aiea, Hawaii, United States
- Saint Alphonsus Cancer Care Center-Boise
Boise, Idaho, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 14 Sept 2009
- Primary completion
- 31 Jan 2015
- Completion
- 6 Mar 2027
- Last update posted
- 8 Jul 2026
- Registered enrollment
- 349
- Registry id
- NCT00977574
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.